Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MM120 in adult ADHD
NCT05200936Phase 2Completed
- Sponsor
- Definium Therapeutics
- Start
- Dec 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of lysergic acid diethylamide D-tartrate in attention deficit hyperactivity disorder (ADHD), sponsored by Definium Therapeutics. Started Dec 2021; status: completed.
02
Drugs
lysergic acid diethylamide D-tartrate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT05200936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05200936.